Syndrome thalamique (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Syndrome thalamique" in French language version.

refsWebsite

Global rank French rank

18doi.org

2^nd place

3^rd place

18nih.gov

4^th place

12^th place

5issn.org

57^th place

4^th place

1rxlist.com

7,927^th place

low place

1griffith.edu.au

low place

5,084^th place

1rarediseases.org

5,181^st place

low place

doi.org

dx.doi.org

V.S. Ramachandran, P. D. McGeoch, L. Williams, McGeoch et Williams, « Can vestibular caloric stimulation be used to treat Dejerine-Roussy Syndrome? », Medical Hypotheses, vol. 69, n^o 3,‎ 2007, p. 486–488 (PMID 17321064, DOI 10.1016/j.mehy.2006.12.036)
H. Klit, N. B. Finnerup, T. Z. Jensen, Finnerup et Jensen, « Central post-stroke pain: clinical characteristics, pathophysiology, and management », The Lancet Neurology, vol. 8, n^o 9,‎ 2009, p. 857–868 (PMID 19679277, DOI 10.1016/S1474-4422(09)70176-0)
R. Hadley, « Dejerine-Roussy Syndrome », Clinical Chiropractic, vol. 7, n^o 2,‎ 2004, p. 79–83 (DOI 10.1016/j.clch.2003.11.003)
G. Wang, S. M. Thompson et Thompson, « Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions », Journal of Neuroscience, vol. 28, n^o 46,‎ 2008, p. 11959–11969 (PMID 19005061, PMCID 2627563, DOI 10.1523/JNEUROSCI.3296-08.2008)
R. L. Quiton, R. Masri, S. M.. Thompson, A. Keller, Masri, Thompson et Keller, « Abnormal activity of primary somatosensory cortex in central pain syndrome », Journal of Neurophysiology, vol. 104, n^o 3,‎ 2010, p. 1717–1725 (PMID 20660417, PMCID 2944690, DOI 10.1152/jn.00161.2010)
D. Bowsher, « Allodynia in relation to lesion site in central post-stroke pain », The Journal of Pain, vol. 6, n^o 11,‎ 2005, p. 736–740 (PMID 16275597, DOI 10.1016/j.jpain.2005.06.009)
U. K. Misra, J. Kalita, B. Kumar, Kalita et Kumar, « A study of clinical, magnetic resonance imaging, and somatosensory-evoked potential in central post-stroke pain », The Journal of Pain, vol. 9, n^o 12,‎ 2008, p. 1116–1122 (PMID 18848810, DOI 10.1016/j.jpain.2008.06.013)
K. Ueda, T. Namiki, Y. Kasahara, A. Chino, H. Okamoto, K. Ogawa, K. Tersawa, Namiki, Kasahara et Chino, « A case of thalamic pain successfully treated with kampo medicine », Journal of Alternative and Complementary Medicine, vol. 17, n^o 6,‎ 2011, p. 567–570 (PMID 21574822, DOI 10.1089/acm.2010.0390)
M. Hayashi, M. F. Chernov, T. Taira, T. Ochiai, K. Nakaya, N. Tamura, S. Goto, S. Yomo, N. Kouyama, Y. Katayama, Y. Kawakami, M. Izawa, Y. Muragaki, R. Nakamura, H. Iseki, T. Hori, K. Takakura, Chernov, Taira et Ochiai, « Outcome after pituitary radiosurgery for thalamic pain syndrome », International Journal of Radiation Oncology * Biology * Physics, vol. 69, n^o 3,‎ 2007, p. 852–857 (PMID 17570607, DOI 10.1016/j.ijrobp.2007.04.043)
J. A. Lopez, L. M. Torres, F. Gala, I. Iglesias, Torres, Gala et Iglesias, « Spinal cord stimulation and thalamic pain: long-term results of eight cases », Neuromodulation, vol. 12, n^o 3,‎ 2009, p. 240–243 (PMID 22151367, DOI 10.1111/j.1525-1403.2009.00221.x)
Clark et Vissel, « Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases », British Journal of Pharmacology, vol. 175, n^o 20,‎ 2018, p. 3859–3875 (ISSN 0007-1188, PMID 30097997, PMCID 6151331, DOI 10.1111/bph.14471)
Tobinick, « Perispinal etanercept advances as a neurotherapeutic », Expert Review of Neurotherapeutics, vol. 18, n^o 6,‎ 2018, p. 453–455 (ISSN 1473-7175, PMID 29695205, DOI 10.1080/14737175.2018.1468253)
Ignatowski, Spengler, Dhandapani et Folkersma, « Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence », CNS Drugs, vol. 28, n^o 8,‎ 2014, p. 679–697 (ISSN 1172-7047, PMID 24861337, PMCID 4110406, DOI 10.1007/s40263-014-0174-2)
Tobinick, Kim, Reyzin et Rodriguez-Romanacce, « Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1051–1070 (ISSN 1172-7047, PMID 23100196, DOI 10.1007/s40263-012-0013-2)
Clark, « New Hope for Survivors of Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1071–1072 (ISSN 1172-7047, PMID 23100197, DOI 10.1007/s40263-012-0014-1)
M. Auer-Grumbach, S. Strasser-Fuchs, K. Wagner, E. Korner, F. Fazekas, Strasser-Fuchs, Wagner et Körner, « Roussy–Lévy syndrome is a phenotypic variant of Charcot–Marie–Tooth syndrome IA associated with a duplication on chromosome 17p11.2 », Journal of the Neurological Sciences, vol. 154, n^o 1,‎ 1998, p. 72–75 (PMID 9543325, DOI 10.1016/S0022-510X(97)00218-9)
C. Haubrich, T. Krings, J. Senderek, S. Zuchner, J. M. Schroder, J. Noth, R. Topper, Krings, Senderek et Züchner, « Hypertrophic nerve roots in a case of Roussy-Levy syndrome », Neuroradiology, vol. 44, n^o 11,‎ 2002, p. 933–937 (PMID 12428130, DOI 10.1007/s00234-002-0847-2)
S. Zubair, N. R. Holland, B. Beson, J. T. Parke, C. I. Prodan, Holland, Beson et Parke, « A novel point mutation in the PMP22 gene in a family with Roussy-Levy syndrome », Journal of Neurology, vol. 255, n^o 9,‎ 2008, p. 1417–1418 (PMID 18592125, DOI 10.1007/s00415-008-0896-5)

griffith.edu.au

(en) « Stroke treatment trial », sur www.griffith.edu.au (consulté le 4 janvier 2021)

issn.org

portal.issn.org

Clark et Vissel, « Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases », British Journal of Pharmacology, vol. 175, n^o 20,‎ 2018, p. 3859–3875 (ISSN 0007-1188, PMID 30097997, PMCID 6151331, DOI 10.1111/bph.14471)
Tobinick, « Perispinal etanercept advances as a neurotherapeutic », Expert Review of Neurotherapeutics, vol. 18, n^o 6,‎ 2018, p. 453–455 (ISSN 1473-7175, PMID 29695205, DOI 10.1080/14737175.2018.1468253)
Ignatowski, Spengler, Dhandapani et Folkersma, « Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence », CNS Drugs, vol. 28, n^o 8,‎ 2014, p. 679–697 (ISSN 1172-7047, PMID 24861337, PMCID 4110406, DOI 10.1007/s40263-014-0174-2)
Tobinick, Kim, Reyzin et Rodriguez-Romanacce, « Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1051–1070 (ISSN 1172-7047, PMID 23100196, DOI 10.1007/s40263-012-0013-2)
Clark, « New Hope for Survivors of Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1071–1072 (ISSN 1172-7047, PMID 23100197, DOI 10.1007/s40263-012-0014-1)

nih.gov

ncbi.nlm.nih.gov

V.S. Ramachandran, P. D. McGeoch, L. Williams, McGeoch et Williams, « Can vestibular caloric stimulation be used to treat Dejerine-Roussy Syndrome? », Medical Hypotheses, vol. 69, n^o 3,‎ 2007, p. 486–488 (PMID 17321064, DOI 10.1016/j.mehy.2006.12.036)
H. Klit, N. B. Finnerup, T. Z. Jensen, Finnerup et Jensen, « Central post-stroke pain: clinical characteristics, pathophysiology, and management », The Lancet Neurology, vol. 8, n^o 9,‎ 2009, p. 857–868 (PMID 19679277, DOI 10.1016/S1474-4422(09)70176-0)
G. Wang, S. M. Thompson et Thompson, « Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions », Journal of Neuroscience, vol. 28, n^o 46,‎ 2008, p. 11959–11969 (PMID 19005061, PMCID 2627563, DOI 10.1523/JNEUROSCI.3296-08.2008)
R. L. Quiton, R. Masri, S. M.. Thompson, A. Keller, Masri, Thompson et Keller, « Abnormal activity of primary somatosensory cortex in central pain syndrome », Journal of Neurophysiology, vol. 104, n^o 3,‎ 2010, p. 1717–1725 (PMID 20660417, PMCID 2944690, DOI 10.1152/jn.00161.2010)
D. Bowsher, « Allodynia in relation to lesion site in central post-stroke pain », The Journal of Pain, vol. 6, n^o 11,‎ 2005, p. 736–740 (PMID 16275597, DOI 10.1016/j.jpain.2005.06.009)
U. K. Misra, J. Kalita, B. Kumar, Kalita et Kumar, « A study of clinical, magnetic resonance imaging, and somatosensory-evoked potential in central post-stroke pain », The Journal of Pain, vol. 9, n^o 12,‎ 2008, p. 1116–1122 (PMID 18848810, DOI 10.1016/j.jpain.2008.06.013)
K. Ueda, T. Namiki, Y. Kasahara, A. Chino, H. Okamoto, K. Ogawa, K. Tersawa, Namiki, Kasahara et Chino, « A case of thalamic pain successfully treated with kampo medicine », Journal of Alternative and Complementary Medicine, vol. 17, n^o 6,‎ 2011, p. 567–570 (PMID 21574822, DOI 10.1089/acm.2010.0390)
M. Hayashi, M. F. Chernov, T. Taira, T. Ochiai, K. Nakaya, N. Tamura, S. Goto, S. Yomo, N. Kouyama, Y. Katayama, Y. Kawakami, M. Izawa, Y. Muragaki, R. Nakamura, H. Iseki, T. Hori, K. Takakura, Chernov, Taira et Ochiai, « Outcome after pituitary radiosurgery for thalamic pain syndrome », International Journal of Radiation Oncology * Biology * Physics, vol. 69, n^o 3,‎ 2007, p. 852–857 (PMID 17570607, DOI 10.1016/j.ijrobp.2007.04.043)
J. A. Lopez, L. M. Torres, F. Gala, I. Iglesias, Torres, Gala et Iglesias, « Spinal cord stimulation and thalamic pain: long-term results of eight cases », Neuromodulation, vol. 12, n^o 3,‎ 2009, p. 240–243 (PMID 22151367, DOI 10.1111/j.1525-1403.2009.00221.x)
Clark et Vissel, « Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases », British Journal of Pharmacology, vol. 175, n^o 20,‎ 2018, p. 3859–3875 (ISSN 0007-1188, PMID 30097997, PMCID 6151331, DOI 10.1111/bph.14471)
Tobinick, « Perispinal etanercept advances as a neurotherapeutic », Expert Review of Neurotherapeutics, vol. 18, n^o 6,‎ 2018, p. 453–455 (ISSN 1473-7175, PMID 29695205, DOI 10.1080/14737175.2018.1468253)
Ignatowski, Spengler, Dhandapani et Folkersma, « Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence », CNS Drugs, vol. 28, n^o 8,‎ 2014, p. 679–697 (ISSN 1172-7047, PMID 24861337, PMCID 4110406, DOI 10.1007/s40263-014-0174-2)
Tobinick, Kim, Reyzin et Rodriguez-Romanacce, « Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1051–1070 (ISSN 1172-7047, PMID 23100196, DOI 10.1007/s40263-012-0013-2)
Clark, « New Hope for Survivors of Stroke and Traumatic Brain Injury », CNS Drugs, vol. 26, n^o 12,‎ 2012, p. 1071–1072 (ISSN 1172-7047, PMID 23100197, DOI 10.1007/s40263-012-0014-1)
M. Auer-Grumbach, S. Strasser-Fuchs, K. Wagner, E. Korner, F. Fazekas, Strasser-Fuchs, Wagner et Körner, « Roussy–Lévy syndrome is a phenotypic variant of Charcot–Marie–Tooth syndrome IA associated with a duplication on chromosome 17p11.2 », Journal of the Neurological Sciences, vol. 154, n^o 1,‎ 1998, p. 72–75 (PMID 9543325, DOI 10.1016/S0022-510X(97)00218-9)
C. Haubrich, T. Krings, J. Senderek, S. Zuchner, J. M. Schroder, J. Noth, R. Topper, Krings, Senderek et Züchner, « Hypertrophic nerve roots in a case of Roussy-Levy syndrome », Neuroradiology, vol. 44, n^o 11,‎ 2002, p. 933–937 (PMID 12428130, DOI 10.1007/s00234-002-0847-2)
S. Zubair, N. R. Holland, B. Beson, J. T. Parke, C. I. Prodan, Holland, Beson et Parke, « A novel point mutation in the PMP22 gene in a family with Roussy-Levy syndrome », Journal of Neurology, vol. 255, n^o 9,‎ 2008, p. 1417–1418 (PMID 18592125, DOI 10.1007/s00415-008-0896-5)

ninds.nih.gov

« Pain: Hope Through Research », National Institute of Neurological Disorders and Stroke, 2011

rarediseases.org

« Thalamic Syndrome (Dejerine Roussy) », National Organization for Rare Disorders, 2003

rxlist.com

Monographie Hydromorphone